Maryam Yazdy
8PUBLICATIONS
63CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Oct 15, 2024
FDA Approval Summary: Polatuzumab Vedotin in the First-Line Treatment of Select Large B-Cell Lymphomas.Maryam Sarraf Yazdy, Yvette L Kasamon, Wenjuan Gu
|Mar 09, 2023
Minimal Residual Disease Data in Hematologic Malignancy Drug Applications and Labeling: An FDA Perspective.Andrea C Baines, Maryam Sarraf Yazdy, Yvette L Kasamon
|Jul 20, 2021
HIV-associated Burkitt lymphoma: outcomes from a US-UK collaborative analysis.Juan Pablo Alderuccio, Adam J Olszewski, Andrew M Evens
|Mar 22, 2020
Assessment of the Efficacy of Therapies Following Venetoclax Discontinuation in CLL Reveals BTK Inhibition as an Effective Strategy.Anthony R Mato, Lindsey E Roeker, Ryan Jacobs
|May 19, 2019
A retrospective comparison of venetoclax alone or in combination with an anti-CD20 monoclonal antibody in R/R CLL.Anthony R Mato, Lindsey E Roeker, Toby A Eyre
|Apr 21, 2019
Tumor Lysis, Adverse Events, and Dose Adjustments in 297 Venetoclax-Treated CLL Patients in Routine Clinical Practice.Lindsey E Roeker, Christopher P Fox, Toby A Eyre
Pageof 2
Frequent Collaborators
4 joint publications
John N Allan
3 joint publications
Christopher P Fox
3 joint publications
Andrea Sitlinger
2 joint publications
Bruce D Cheson
2 joint publications
Yvette L Kasamon
2 joint publications
Toby A Eyre
2 joint publications
Frederick Lansigan
2 joint publications
Paul M Barr
2 joint publications
Joanna Rhodes
2 joint publications
Sivraj Muralikrishnan
